REAP Conference 2024 registration is open
Book tickets, feature in the technology exhibition or apply for a REAP bursary - available for farmers and those in full-time agriculture-related study

PBD Biotech

Technology
Visit Site
PBD Biotech has developed a rapid diagnostic that detects and identifies mycobacteria causing bovine TB and Johne’s disease from a single sample of blood.
About
In the News
Back to Member Directory
About

About

Actiphage, a novel phage-based technology, is able to sensitively detect the presence of live bacteria in blood or milk. It offers early stage detection of both bTB and Johne’s Disease before the carrier becomes infective, enabling for the first time preventative management of these economically damaging diseases.

Unlike the existing gold-standard skin test for bovine TB  which measures the immune response of the animal,  Actiphage test directly identifies the presence of live bacteria and so can be used to distinguish vaccinated from unvaccinated animals.

Actiphage can also be used as a milk test for quality assurance of dairy products.

Actiphage has been successfully used to detect live mycobateria in raw milk, pasteurised milk, powdered infant formula, cheese and in the blood of infected animals. The highly sensitive and specific test has been applied to samples from 17 species so far, including cattle, camelids and exotic animals.

PBD Biotech has raised funding for trials to take Actiphage for international validation by the World Organisation for Animal Health (OIE). The test has been approved for use in England and Wales by the Animal & Plant Health Agency (APHA) for exceptional private use in areas of chronic TB breakdowns. Other international trials are underway

In the News

In the News